Analysis of p53-dependent mechanisms in the maintenance of genetic stability in diploid tumourigenic line SK-UT-1B of human uterine leiomyosarcoma

Cell Biology International

Volumn 25, Issue 11, 2001, Pages 1101-1115

  Smirnova, Irina S ^a   Yakovleva, Tatyana K ^a   Rosanov, Yurii M ^a   Aksenov, Nikolai D ^a   Pospelova, Tatyana V ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

Apoptosis; Checkpoints of cell cycle; p53; Stability of genome

Indexed keywords

PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE; CELL POPULATION; CELL PROLIFERATION; CHROMOSOME MARKER; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DIPLOIDY; GAMMA IRRADIATION; GENETIC STABILITY; HUMAN; HUMAN CELL; KARYOTYPE; LEIOMYOSARCOMA; PLASMID; POLYPLOIDY; REPORTER GENE; UTERUS SARCOMA;

EID: 0035210261     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.2001.0709     Document Type: Article

References (45)

1. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
2. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice
3. Mutations of mitotic checkpoint genes in human cancers
4. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer
5. SK-UT-1B, a human tumorigenic diploid cell line
6. SK-UT-1B cell line has the diploid karyotype
7. Coexisting clones in diploid and near-diploid cell lines
8. A p53 dependent mouse spindle checkpoint
9. CIPI/ undergo normal development, but are defective in G1 checkpoint control
10. Deficiency of p53 accelerates mammary tumorigenesis in Wnf-1 transgenic mice and promotes chromosomal instability
11. WAF1, a potential mediator of p53 tumor suppression
12. Abnormal centrosome amplification in the absence of p53
13. Genomic instability and apoptosis are frequent in p53 deficient young mice
14. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
15. Cell cycle control and cancer
16. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice
17. Chromosome error propagation and cancer
18. Database of p53 gene somatic mutations in human tumors and cell lines
19. Cancer therapy meets p53
20. Genetic instability in colorectal cancers
21. p53, the cellular gatekeeper for growth and division
22. Molecular controls of growth arrest and apoptosis: p53 dependent and independent pathways
23. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
24. Mutator phenotype may be required for multistage carcinogenesis
25. p53 is required for radiation-induced apoptosis in mouse thymocytes
26. Inactivation of p53 results in high rates of homologous recombination
27. Testing the role of p53 in the expression on genetic instability and apoptosis in ataxia-telangiectasia
28. P16/MTSI and pRB expression in endometrial carcinomas
29. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
30. Mechanisms of tumour progression
31. A simple tripsin-Giemza technique producing simultaneous G- and C-banding in human chromosomes
32. When checkpoint fail
33. The role of p53 in the induction of polyploidity of myelomonocytic leukemic M1/2 cells
34. Induction of apoptosis by wild-type p53 in a human colon tumour-derived cell line
35. Evidence for a second cell cycle block at G2/M by p53
36. p53 is linked directly to homologous recombination processes via RAD5/RecA protein interaction
37. Enhanced proliferative potential in culture of cells from p53-deficient mice
38. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
39. DNA-damage and checkpoint pathways: Molecular anatomy and interaction with repair
40. Enhanced protein stability: A novel mechanism of D-type cyclin overabundance identified in human sarcoma cells
41. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins
42. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
43. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6